Patent · US Active

Compositions and methods for genome engineering with Cas12a proteins

US11434478B2 · kind B2 · utility

0Cited by
2References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 9, 2021
Grant dateSep 6, 2022
Priority date
Expiry dateFeb 9, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides novel Cas12a proteins, which cleave target nucleic acids and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.